Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose. Linked wirelessly to the cloud, smart inhalers are a part of “Internet of Things,” thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of the dose, which can be recorded for understanding the patient’s daily routine.
The world smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Under the moderate growth scenario, smart inhalers market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, due to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor for the growth of smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance towards adoption of smart inhalers are expected to hinder the market growth.
The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD. On the basis of end user, it is divided into patients and R&D. In terms of geography, the market is analyzed into North America, Europe, Asia-Pacific, and LAMEA.
North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3%, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.
Companies have adopted product approval and clinical trials as their key development strategies. Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers. In March 2016, Adherium received a product approval to sell its “SmartTurbo” and “SmartTouch” devices in Canada, thereby expanding its product portfolio.
Key players operating in the market include:
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
By End User
Eye Anatomical Model is a kind of models to study and explain the internal and external structure of the eyes. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from the realism of the models. Scope of the Report: This report focuses on the Eye ...
February 2018 | $4880 |View Details>>
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses. Scope of the Report: This ...
February 2018 | $3480 |View Details>>
In this report, the global Blood Warmer market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, ...
February 2018 | $2900 |View Details>>
In this report, the global Venous Catheter market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, ...
February 2018 | $2900 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2018 © Copyright Big Market Research